baber/WOPTO huggingface dataset:
Patent NZ-294274-A (NZ)
Title: Cistern discharge valve with main and pilot valves
Inventor: FROST DOUGLAS ROBERT DAVID
IPC: E03D1/14
Filed: 1995-10-23
Abstract: PCT No. PCT/GB95/02493 Sec. 371 Date Aug. 8, 1997 Sec. 102(e) Date Aug. 8, 1997 PCT Filed Oct. 23, 1995 PCT Pub. No. WO96/14479 PCT Pub. Date May 17, 1996An improved discharge valve comprises an upper housing, an upwardly movable main valve assembly within the housing and forming with the upper part thereof a variable volume upper chamber, a restricted passage between the upper chamber and the exterior thereof, an outlet leading down from the lower part of the housing, a seat for the main valve assembly at the entry to the outlet so that, in the lowered position of the main valve assembly, the outlet is blocked against ingress of fluid in which the device is immersed, and a pilot stem actuable remotely from the housing to put the upper chamber in free communication with the outlet. The arrangement being such that, once such free communication is established, fluid escapes the upper chamber and the change in relative pressures above and below the main valve assembly causes the latter to unseat thereby permitting flow of the immersing fluid into the outlet and its substantially complete discharge. The cessation of flow of the immersing fluid allows the main valve assembly to revert to its seated position with the pilot stem cutting off free communication, and air penetrates the upper chamber and on replenishment of immersing fluid, a net downward pressure is created on the main valve assembly to keep it seated. The pilot valve has a hollow stem communicating to atmosphere above the normal full set level of fluid in the cistern. The main valve assembly and the hollow stem define therebetween a hollow annulus.
Patent NZ-315505-A (NZ)
Title: Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands
Inventor: RILEY DENNIS P
IPC: A61K51/04
Filed: 1996-08-16
Abstract: he application is directed to complexes represented by formula (I), which are suitable for use as contrast agents in diagnostic imaging.
Patent NZ-316543-A (NZ)
Title: Display screens incorporating loudspeakers
Inventor: AZIMA HENRY
IPC: H04R5/02
Filed: 1996-09-02
Abstract: A display screen (32), e.g. a projection screen comprising a panel having a light reflective surface, characterised in that the screen is a distributed mode acoustic radiator loudspeaker having a transducer (9) mounted wholly and exclusively thereon to vibrate the radiator to cause it to resonate to provide an acoustic output.
Patent NZ-319199-A (NZ)
Title: Canned foodstuff comprising a mixture of metal protein, gelling system and chemical leavening agent
Inventor: MUSSON GARY DAVID
IPC: A23L13/40
Filed: 1996-09-26
Abstract: The invention provides a canned foodstuff comprising discrete chunks, the chunks comprising a food material and being substantially free of intervening liquid, gel or other matrix material. Preferably, the chunks are of a leavened foodstuff comprising a gelled mixture comprising meat protein.  The leavening agent being a hydrogen carbonate of an alkali metal, preferably potassium and activated by a change in pH. Also claimed is a method of making a foodstuff comprising forming a mixture of meat protein and a gelling system (starch) and leavening the mixture while gelling it, cutting the gelled mixture into chunks, sealing the gelled mixture in a container with a liquid and heating the contents of the container so that the liquid is absorbed by the gelled mixture.
Patent NZ-336539-A (NZ)
Title: Peptide-lipid conjugates, liposomes and liposomal drug delivery
Inventor: MEERS PAUL R
IPC: C07K5/08
Filed: 1997-10-15
Abstract: Peptide-lipid conjugates of the formula above, wherein X is a bond or R3, Y is an enzyme cleavable peptide group and each of R1, R2 and R3 are independently a group having the formula C(O)(CH2)n1(CH=CH)n2(CH2)n3(CH=CH)n4(CH2)n5(CH=CH)n6(CH2)n7(CH=CH)n8(CH2)n9CH3: wherein n1 is from 0-22, n3 is from 1-19, n5 is from 1-16, n7 is from 0-13, n9 is from 0-10, each n2, n4, n6 and n8 is independently selected from 0 and 1, and for each R1 and R2 independently the sum of n1 + 2n2 + n3 + 2n4 + n5 + 2n6 + n7 + 2n8 + n9 is from 12-22 and for R3 the sum of n1 + 2n2 + n3 + 2n4 + n5 + 2n6 + n7 + 2n8 + n9 is from 0-22, are incorporated into liposomes so as to selectively destabilize the liposomes in the vicinity of target peptidase-secreting cells, and hence, to deliver the liposomes to the vicinity of the target cells, or directly into the cells. The liposomes can be used to treat mammals for diseases, disorders or conditions, e.g., tumors, microbial infection and inflammations, characterized by the occurrence of peptidase-secreting cells.
Patent NZ-500652-A (NZ)
Title: C-4"-substituted macrolide derivatives
Inventor: BRONK BRIAN SCOTT
IPC: A61P31/04
Filed: 1998-05-25
Abstract: Compounds of formula (1) and to pharmaceutically acceptable salts thereof are described. The compounds of formula (1) are potent antibacterial agents that may be used to treat various bacterial infections and disorders related to such infections.  Also described are methods of preparing the compounds of formula (1).
Patent NZ-500938-A (NZ)
Title: Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
Inventor: JOHNSON DAVID A
IPC: A61K31/70
Filed: 1998-05-07
Abstract: An immunoeffector compound of the provided structure wherein, X is selected from the group consisting of O and S; Y is selected from the group consisting of O and NH; n, m, p and q are integers from 0 to 6; R1, R2 and R3 are the same or different and are normal fatty acyl residues having from about 7 to about 16 carbon atoms; R4 and R5 are the same or different and are selected from the group consisting of H and methyl; R6 and R7 are the same or different and are selected from the group consisting of H, hydroxy, alkoxy, phosphono, phosphonooxy, sulfo, sulfooxy, amino, mercapto, cyano, nitro, formyl, carboxy, and esters and amides thereof; and R8 and R9 are the same or different and are selected from the group consisting of phosphono and H, and at least one of R8 and R9 is phosphono. The compound can also be used in a vaccine or pharmaceutical compositions for enhancing the immune response of a mammal.
Patent NZ-503121-A (NZ)
Title: Key step to synthesis of reverse transcriptase inhibitor (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one (DMP-266) where the step of protection deprotection step is eliminated
Inventor: REIDER PAUL J
IPC: C07C213/10
Filed: 1998-09-01
Abstract: A process for enhancing the purity of 2R-[1-hydroxy- 1-trifluoromethyl- 3-cyclopropylpropyn-2-yl] -4-chloroaniline comprising the formation of an acid addition salt which is capable of rejecting the racemate in the selected organic solvent. The process for enhancing the optical purity of the R-amino alcohol of formula described comprised the steps of:  (a) adding slowly an acid solution or gas to a solution of the amino alcohol in an organic solvent to form a slurry of the acid addition salt of the amino alcohol; (b) concentrating the slurry of the amino alcohol acid addition salt of the amino alcohol; (c) flushing the concentrated slurry of the amino alcohol acid addition salt with organic solvent to adjust the solvent composition; (d) aging the slurry of the amino alcohol acid addition salt at ambient temperature for about 2 hours to about 24 hours; (e) filtering the aged slurry of the amino alcohol acid addition salt to isolate a wetcake of the amino alcohol acid addition salt; washing the wetcake of the amino alcohol acid addition salt with cold organic solvent; and (f) drying the wetcake of the amino alcohol acid addition salt to isolate the amino alcohol acid addition salt as a solid with enhanced optical purity.
Patent NZ-505530-A (NZ)
Title: Cytokine related treatments of disease using a nucleoside
Inventor: TAM ROBERT
IPC: A61K31/70
Filed: 1998-01-13
Abstract: A use of a first compound and a second compound in the manufacture of a medicament for the treatment of a disease which is known to produce an abnormality in at least one cytokine in a patient, wherein the first compound has a known monotherapeutic dosage which is effective to threat the disease, wherein the second compound exacerbates the abnormality when administered within a dosage range, and wherein the medicament is formulated, so that when administered, the medicament provides to the patient a first compound at less than the monotherapeutic dosage and the second compound outside the dosage range.
Patent NZ-506701-A (NZ)
Title: Therapy of estrogen-associated disorders using isoflavones form clover or chick pea
Inventor: KELLY GRAHAM EDMUND
IPC: A61P15/00
Filed: 1999-03-26
Abstract: A composition containing an isoflavone extract of clover or chick pea, containing biochanin and one or more of the isoflavones from: formononetin, daidzein and genistein at a ratio from about 2:1 to about 5:1.
Patent NZ-511320-A (NZ)
Title: Heat sink manufacturing device and manufacturing method
Inventor: OOTORI YASUHIRO
IPC: H01L21/48
Filed: 2000-09-06
Abstract: A device and method for manufacturing a heat sink that has a base and heat radiating fins of various shapes and has a prescribed strength, high radiating efficiency, and whose base and heat radiating fins are formed integrally.  A heat sink manufacturing device according to the present invention includes a fixed mold, a vertical or up-down direction, and a slide mold that can move in the horizontal direction.
Patent NZ-514161-A (NZ)
Title: Multifunctional reagent for erythrocytes
Inventor: VAN AGTHOVEN ANDRE
IPC: A61K35/18
Filed: 2001-09-13
Abstract: A multifunctional reagent for erythrocytes containing a carbamate or an agent which induces the formation of carbamate from carbonate and a nitrogenated heterocycle or ammonium ions during the absorption of CO2 by said erythrocytes, wherein said carbamate or said agent is present in a quantity sufficient to produce the lysis or sphering  of erythrocytes such that said erythrocytes can be detected by a cytometer or an automatic counting device.
Patent NZ-514966-A (NZ)
Title: Thin lithium film battery
Inventor: JOHNSON LONNIE G
IPC: H01M4/66
Filed: 2000-03-31
Abstract: A rechargeable, thin film lithium battery cell is provided having an aluminum cathode current collector (11) having a cobalt coating sandwiched between two crystallized cathodes (12). Each cathode has an electrolyte (13) deposited thereon which is overlaid with a lithium anode (14). An anode current collector (16) contacts the anode and substantially encases the cathode collector, cathode, electrolyte and anode. An insulator occupies the spaces between these components and the anode current collector.
Patent NZ-516048-A (NZ)
Title: Machine-assisted exercising
Inventor: DREISSIGACKER RICHARD A
IPC: A63B21/008
Filed: 2000-06-02
Abstract: An  exercise machine (10) in which a fan  (12)  has  a rotor  that  generates  drag  by  causing  air  to  move  in response  to  exercising by a user. A  deflection  structure deflects  air that the rotor has moved and is adjustable  to control the amount of drag generated by the rotor.
Patent NZ-518727-A (NZ)
Title: Bank cheque system with cheques having magnetized strips and/or storage chips
Inventor: AL AMRI MOOSA EISA
IPC: G07D7/00
Filed: 2000-11-21
Abstract: A bank cheque system comprises issued bank cheques (20) each having a front face carrying imprinted visible data (written) (11-21), a rear face for endorsement, and a magnetic strip (30) and/or storage chip (33) in which invisible data (11-21) is encoded on the front and/or rear face, the issued cheques each comprises a thin portion carrying the imprinted and written visible data and a thick portion (32) made of plastic wherein the magnetic strip (30) and/or storage chip (33) is/are merged, the stored encoded data in the thick portion (32) of the cheque is readable by means of a suitable reader so its conformity with the visible data can be verified to detect any unauthorised alterations to the cheque , the stored encoded data includes and identification of a cheque, bank and an account containing blocked funds available for the cheque to be paid or endorsed as a cash instrument, wherein: (i) the visible data (imprinted and written) and stored encoded data each indicate a value of the cheque, the value is covered by a pre-paid amount credited to the cheque account; and/or (ii) the visible data (imprinted and written) and stored encoded data (stored on the magnetized strip or storage chip) each identify a current account from which the cheque account can be funded to cover the sufficient blocked amount on presentation of the cheque and after ascertaining, by passing or entering the cheque though a reader connected to a banking control system, and entering the value of the cheque, that the current account has a sufficient credit.
Patent NZ-521465-A (NZ)
Title: Use of non-spreading silicone surfactants in agrochemical compositions
Inventor: HUMBLE GEOFFREY DAVID
IPC: A01N55/10
Filed: 2002-09-18
Abstract: Increasing the rainfastness and efficacy of an agrochemical composition without increasing its spreading properties which comprises adding to an agrochemical composition an effective amount of one or more silicone surfactants of the formula R3Si-O-[RR'SiO-]n-O-SiR3, wherein; n is 1 to 3; R is an alkyl radical with 1 to 6 carbon atoms; R' is a radical of the structure -(CH2)m-O-(C2H4O)y(C2H3R''O)z-Z, wherein; m is 2 to 6; R'' is independently methyl, ethyl or phenyl; Z is hydrogen, an alkyl radical with 1 to 4 carbon atoms, or an acyl radical with 2 to 6 carbon atoms, y is 6 to 30 z is 0 to 10 with the proviso that the ratio y/z is 1 or greater, and that the total number of alkylene oxide groups n* (y+z) in the siloxane polymer is at least 12.
Patent NZ-522096-A (NZ)
Title: Truck deck tilting mechanism
Inventor: ARMOUR BARRY DOUGLAS
IPC: B60P3/07
Filed: 2002-10-22
Abstract: A truck with a chassis and cab. A deck is supported by a rearmost axle and wheels by a suspension arrangement with the forward part of the suspension operatively connected to the chassis and a rear part of the suspension arrangement operatively connected to the deck or deck support frame wherein the deck is tiltable relative to the chassis about a pivot axis located in front of the rearmost axle of the truck and arranged such that as the deck tilts rearward, the chassis tilts forward and the forward part of the suspension arrangement moves upwardly relative to the deck, thereby lowering the deck towards the rearmost axle.
Patent NZ-526967-A (NZ)
Title: Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damaging cutaneous tissue
Inventor: LYSTER HANS BRINCH
IPC: A61P17/02
Filed: 2002-01-16
Abstract: Use of at least one cyanoacrylate compound alone or combined for producing a medicament for prophylactic or therapeutic treatment of diseases in and related to humane dermal tissue or humane mucous tissue is disclosed. The medicament offers an advantageous alternative to hitherto known medicaments for treatment of exanthemaes, psoriasis exanthemaes, exanthemaes in connection with fungal infections, virus infections, cutaneous tissue and revision of infected and non-infected wounds.
Patent NZ-531466-A (NZ)
Title: Use of single nucleotide polymorphisms (SNPs) to identify individuals in forensic investigations
Inventor: GILL PETER
IPC: C12Q1/68
Filed: 2000-07-24
Abstract: Described are techniques for investigating DNA samples, which offers improved sensitivity and specificity. Provided is a method of investigating single nucleotide polymorphisms (SNPs) in a sample of DNA, the method comprising contacting the DNA containing sample with at least one first set of primers, amplifying the DNA using those primers to give an amplified product, contacting at least a portion of the amplified product with at least one second set of primers, amplifying the DNA using those second set of primers to give a further amplified product and examining one or more characteristics of the further amplified product, one or more of the primers of the first set of primers including a locus specific portion and a further portion, the locus specific portion of one of those one or more of the primers annealing to one side of the SNP under investigation. (62) Divided out of 517116
Patent NZ-535930-A (NZ)
Title: System and method of embryo delivery for manufactured seeds
Inventor: HIRAHARA EDWIN
IPC: A01G9/10
Filed: 2004-10-14
Abstract: A method of delivering embryos comprising the steps of: positioning at least one embryo located on a support surface in a retrieval position; retrieving the oriented embryo with automated microtweezers by actuation of the microtweezers to a closed position, wherein the microtweezers are movable between a retrievable and a release position; moving the microtweezers to the release position; and releasing the embryo into the seed coat by actuation of the microtweezers to an open position.
Patent NZ-537681-A (NZ)
Title: Oral care composition comprising tropolone compounds and essential oils
Inventor: PAN PAULINE CHU
IPC: A61K31/12
Filed: 2003-07-17
Abstract: Disclosed is an oral care composition comprising an oral care effective amount of: (a) a tropolone compound selected from the group consisting of methyl-7-hydroxymethyltropolone, 4-methyl-7-methoxymethyltropolone, 4,7-dimethyltropolone, 7-methyl-4-isopropyltropolone, 7-hexyl-4-isopropyltropolone, 4-t-butyltropolone, 5-t-butyltropolone, 4-methyltropolone, 7-methoxymethyl-4-isopropyltropolone, 7-hexloxymethyl-4-isopropyltropolone and combinations thereof; (b) at least one essential oil, and (c) a pharmaceutically acceptable oral carrier. These oral care compositions are used in the manufacture of a medicament for treating or preventing diseases or conditions of the oral cavity in warm-blooded animals including humans, wherein the medicament may be formulated in a form selected from the group consisting of toothpastes, mouthwashes, gels, tooth powders, film forming dentifrices, chewing gums, mouth sprays and lozenges.
Patent NZ-542365-A (NZ)
Title: Power supply system comprising rechargeable battery pack and attachment apparatus
Inventor: WADSWORTH JOHN F
Filed: 2005-09-14
Abstract: A power supply system capable of providing electric power to an electronic device having a first battery includes a battery pack ( 100 ) and an attachment apparatus ( 300 ). The battery pack includes a body ( 110 ) having at least a first recess ( 221 ), a second battery inside the body, and at least one of a first circuit capable of dynamically changing a charge current supplied to the second battery based on a power consumption level of the electronic device, and a second circuit capable of dynamically switching the electronic device between a recharging state and a non-recharging state depending on a status of the battery pack. The attachment apparatus includes a frame ( 310 ), an extension ( 350 ) protruding from the frame, and attachment features ( 461 ) suitable for working with the recess to attach the battery pack and the attachment apparatus to each other and to the electronic device.
Patent NZ-544554-A (NZ)
Title: Recombinant adeno-associated virus vector for expressing beta-amyloid peptide in intestinal cells to treat Alzheimer's disease
Inventor: TABIRA TAKESHI
IPC: A61K35/76
Filed: 2004-06-11
Abstract: Disclosed is the use of an adeno-associated virus vector in the manufacture of a therapeutic agent to express the beta-amyloid peptide in intestinal cells for the treatment of Alzheimer's disease, wherein the adeno-associated virus vector comprises DNA encoding said beta-amyloid peptide and DNA encoding a signal peptide capable of extracellularly secreting said beta-amyloid peptide, in an operative form.
Patent NZ-546272-A (NZ)
Title: The modulation of hyaluronan synthesis and degradation in the treatment of disease
Inventor: BROWN TRACEY JEAN
IPC: A61P35/00
Filed: 2004-10-11
Abstract: Disclosed is an isolated nucleic acid based compound which reduces the level of hyaluronan synthase (HAS) activity wherein said compound specifically targets a nucleic acid molecule encoding SEQ ID NOs:24, 25 or 26 or encoding a sequence containing one or more conservative amino acid substitutions of SEQ ID NOs:24, 25 or 26, wherein said nucleic acid based compound is selected from an anti-sense molecule, a sense molecule, an siRNA, a dsRNA, an RNAi, a ribozyme, an oligomeric compound, an oligonucleotide and a DNAzyme.
Patent NZ-550226-A (NZ)
Title: Novel crystalline form of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid (pradofloxacin trihydrate)
Inventor: RAST HUBERT
IPC: A61K31/4709
Filed: 2005-03-19
Abstract: Disclosed is pradofloxacin trihydrate, and its use in treating bacterial disorders.
Patent NZ-555449-A (NZ)
Title: Matrix converters
Inventor: CRANE ALLAN DAVID
IPC: H02M7/162
Filed: 2005-12-16
Abstract: A matrix converter comprises three ac voltage lines, two dc voltage lines; a first switch connected between a first one of the three ac voltage lines and an alpha one of the two dc voltage lines, a second switch connected between a second one of the three ac voltage lines and the alpha one of the two dc voltage lines, a third switch connected between a third one of the three ac voltage lines and the alpha one of the two dc voltage lines, a fourth switch connected between the first one of the three ac voltage lines and a beta one of the two dc voltage lines, a fifth switch connected between the second one of the three ac voltage lines and the beta one of the two dc voltage lines, and a sixth switch connected between the third one of the three ac voltage lines and the beta one of the two dc voltage lines, such that each of the three ac voltage lines can be connected to one of the two dc voltage lines when the associated switch is closed; and a freewheel path between the two dc voltage lines that includes a reverse blocking device. The first, second, third, fourth, fifth and sixth switches are bi-directional such that the matrix converter can be used for motoring applications where a three-phase ac input voltage is supplied to the three ac voltage lines from a supply network and rectified by the matrix converter to provide a dc output voltage on the two dc voltage lines and for generating applications where a dc input voltage is supplied to the two dc voltage lines and inverted by the matrix converter to provide an ac output voltage on the three ac voltage lines. The first, second, third, fourth, fifth and sixth switches are controlled using pulse width modulation to connect the dc voltage lines to the appropriate ac voltage lines or to none of the ac voltage lines during a motoring application with the dc voltage lines having respective dc voltage polarities and to connect the three ac voltage lines to the appropriate dc voltage line or to none of the dc voltage lines during a generating application with the dc voltage lines having the same respective dc voltage polarities such that the matrix converter is adapted to regulate bi-directional power flow whilst retaining a uni-directional dc voltage. A power conversion method using the matrix converter as described above comprises the steps of: supplying a momentary sample of an ac voltage to the dc voltage lines; and opening the first, second, third, fourth, fifth and sixth switches of the matrix converter so that the dc current flows through the freewheel path. A power converter comprises a matrix converter the matrix converter as described above and an inverter.